We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

Product News   Jun 20, 2018

 
CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

Credit: CIRCULOGENE

 
 
FURTHER INFORMATION
 
 
 

Related Product News

QIAGEN Launches First FDA-approved Companion Diagnostic Using FGFR Alterations to Help Guide the Treatment of Metastatic Urothelial Cancer

Product News

Novel therascreen® FGFR RGQ RT-PCR Kit will aid in identifying patients eligible for treatment with BALVERSA™ (erdafitinib), developed by Janssen.

READ MORE

Top UK University Is Successfully using Syngene Imaging System to Rapidly Study Proteins, DNA and Cells Associated with Breast Cancer

Product News

G:BOX Chemi XX6 multi-application imager is being utilised by scientists at a major London university to speed up analysis of proteins, DNA and cells associated with breast and a range of other cancer types.

READ MORE

Senior Appointments Enhance Sygnature Discovery’s DMPK Capabilities

Product News

Dr Stuart Best, Dr Hayley Butler, Dr Daniel Weston and Dr Bodo Spöri have all joined the senior management team of the company’s DMPK department.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE